Status:
COMPLETED
Transesophageal Echocardiography: Dysphagia Risk in Acute Stroke (T.E.D.R.A.S. Trial)
Lead Sponsor:
University of Giessen
Conditions:
Acute Stroke
Dysphagia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The prevalence of dysphagia in acute stroke patients undergoing transesophageal echocardiography (TEE) is unknown. The aim of this study was to assess for the first time whether TEE has a negative inf...
Detailed Description
Dysphagia is common in patients with acute stroke and deteriorates the overall outcome (1). Transesophageal echocardiography (TEE) is a routine examination in the diagnostic workup of stroke etiology....
Eligibility Criteria
Inclusion
- acute stroke (max. 7 days post-onset) as displayed by a cranial computed tomography (CT) or magnetic resonance imaging (MRI)
- written informed consent either by patients themselves or by a legal representative
- indication for TEE
Exclusion
- brain hemorrhage
- either pre-existing neurogenic dysphagia or
- head-and-neck cancer induced dysphagia
- dementia
- aphasia with an impairment in language comprehension
Key Trial Info
Start Date :
June 12 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04302883
Start Date
June 12 2013
End Date
October 1 2019
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Giessen and Marburg
Giessen, Hesse, Germany, 35392